Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Beta-carotene is a precursor to vitamin A, an essential nutrient for maintaining healthy vision. Its antioxidant properties have led to investigation into its potential role in preventing or slowing the development of cataracts, which are caused by the clouding of the eye's lens, often related to oxidative stress. Several observational studies have shown that diets high in carotenoids, including beta-carotene, are associated with a reduced risk of cataract formation. However, randomized controlled trials have yielded mixed results.

The most notable research comes from large studies such as the Age-Related Eye Disease Study (AREDS) and AREDS2. While these studies found that certain antioxidant combinations (vitamin C, vitamin E, zinc, and copper) could slow the progression of age-related macular degeneration, beta-carotene was not specifically shown to provide a significant benefit for cataract prevention or treatment. In fact, in the AREDS2 trial, beta-carotene was replaced with lutein and zeaxanthin due to concerns about increased lung cancer risk in smokers.

In summary, while there is some scientific rationale and limited evidence from observational studies supporting beta-carotene’s role in cataract prevention, high-quality clinical trial evidence does not robustly support its use. Therefore, beta-carotene is sometimes recommended based on its general antioxidant properties, but it is not a primary or strongly supported intervention for cataracts.

More about beta-carotene
More about Cataracts

Other ingredients used for Cataracts

Other health conditions supported by beta-carotene

Products containing beta-carotene